Are you Dr. Iqbal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 63 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
1 Maloney
Philadelphia, PA 19104Phone+1 215-662-2300- Is this information wrong?
Summary
- Dr. Nayyar Iqbal, MD is an endocrinologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and Illinois. He is affiliated with Hospital of the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center.
Education & Training
- Indiana University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1997
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1992 - 1995
- Aga Khan Medical CollegeClass of 1990
Certifications & Licensure
- PA State Medical License 1997 - 2024
- IL State Medical License 1992 - 1999
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes Start of enrollment: 2004 Sep 01
- Chromium Picolinate for the Treatment of Metabolic Syndrome Start of enrollment: 2004 Jan 01
Publications & Presentations
PubMed
- 103 citationsRandomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 DiabetesChantal Mathieu, Aurelian Emil Ranetti, Danshi Li, Ella Ekholm, William Cook
Diabetes Care. 2015-11-01 - 66 citationsRandomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes.Stephan Matthaei, Doina Catrinoiu, Aleksander Celiński, Ella Ekholm, William Cook
Diabetes Care. 2015-11-01 - 1191 citationsEffects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz, Vivian P. Thompson, Yuliya Lokhnygina
The New England Journal of Medicine. 2017-09-14
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
- Philadelphia Veterans Affairs Medical CenterPhiladelphia, Pennsylvania